RTX Corp is a large-cap aerospace and defense company with a market value near $282 billion that operates in aircraft engines, engine parts and broader defense systems. The business supplies propulsion, avionics and other systems used on manned and unmanned platforms, placing it squarely on the Defense Autonomy theme because those product lines feed into autonomous and remotely operated platforms.
The revenue trend shows a multi-quarter recovery and growth. Revenue rose from $13.46 billion in CY2023Q3 to $24.71 billion in CY2026Q2, an increase of roughly 83% over that period, and the most recent quarter printed revenue of $24.71 billion, up 14.5% year over year. Earnings per share moved from negative territory in 2023Q3 (EPS -$0.68) to a run of positive quarters above $1.00, with EPS at $1.57 in CY2026Q2, up about 28.7% year over year. Growth is consistent, but the company’s revenue and EPS are not flagged as accelerating, and quarterly EPS has shown volatility in prior periods.
Exposure to Defense Autonomy comes through scale across engines, avionics and defense systems, which could benefit if defense customers increase spending on autonomous capabilities. The combination of steady revenue growth, a return to consistent positive EPS, and the company’s existing participation in propulsion and systems makes RTX a way to track Defense Autonomy at large scale while carrying the typical aerospace and defense profile of program timing and execution risk.
Why now
The timing follows a strong CY2026Q2 result — $24.71 billion revenue and $1.57 EPS, +14.5% and +28.7% year over year — while the share price is tracking above both the 50-day and 200-day moving averages and has outperformed the S&P over the past 3 and 12 months; that combination of improving fundamentals and constructive price action puts RTX on the radar for exposure to Defense Autonomy.
The setup
Last close was $209.22 (as of 2026-08-24), above the 50-day average ($203.86) and the 200-day average ($191.71). The stock is in Weinstein Stage 2 after breaking above the rising 200-day line 44 sessions ago. Relative strength has outpaced the S&P (excess return +15.8% three months, +13.7% 12 months), volume internals show accumulation with a 50-day up/down volume ratio of 1.39, and the RSI sits near neutral at 43.9.
Revenue trajectory
Quarterly revenue with year-over-year growth. Solid bars are actuals from SEC EDGAR filings (XBRL); dashed bars are analyst consensus via Yahoo Finance (22 analysts).Earnings trajectory
Solid bars are quarterly GAAP diluted EPS from SEC EDGAR filings. Dashed bars are analyst consensus, which is typically adjusted (non-GAAP). The two are measured differently, so a step between the last actual and the first estimate usually reflects that change in basis rather than a change in the business.Analyst full-year EPS consensus (typically adjusted): FY'26E $7.24 (+15%) · FY'27E $7.86 (+8%) — 22 analysts
Risks
Two key risks are variability in defense and aerospace program timing and contract awards, which can swing quarterly revenue and backlog, and execution or supply-chain problems on large engine or systems programs that would pressure margins and EPS. A third risk is earnings volatility: EPS moved from negative in 2023 to positive and has shown wide quarter-to-quarter swings, meaning forward expectations can be sensitive to single-program results or cost items.
Framework fit
CANSLIM
4/7- CCurrent quarterly GAAP EPS growth ≥ 25%+29%✓
- AAnnual GAAP EPS growth ≥ 25%insufficient data—
- NNew highs — within 15% of 52-week high-7.22%✓
- SSupply/demand — up-day volume leads1.39x✓
- LLeader — outperforming the S&P 500-8% 6m✕
- IInstitutional sponsorship——
- MMarket in a confirmed uptrendConfirmed uptrend✓
Minervini Trend Template
7/7Stage 2 confirmation checklist: price versus rising long-term moving averages and the 52-week range.
Weinstein Stage
Broke above the rising 200-day line 44 sessions ago — the classic Stage 1-to-2 transition zone.